Pacientes con trastorno por uso de alcoholresultados iniciales de un registro multicéntrico en la Red de Trastornos Adictivos-RTA. Estudio CohRTA

  1. Arantza Sanvisens 1
  2. Paola Zuluaga 1
  3. Inmaculada Rivas 2
  4. Gabriel Rubio 3
  5. Antoni Gual 4
  6. Marta Torrens 5
  7. Antoni Short 6
  8. Francisco Javier Álvarez 7
  9. Jordi Tor 5
  10. Magí Farré 5
  11. Fernando Rodríguez de Fonseca 8
  12. Roberto Muga 5
  1. 1 Institut d’Investigació Germans Trias i Pujol-IGTP, Badalona
  2. 2 Institut Municipal de Serveis Personals, Badalona
  3. 3 Servicio de Psiquiatría, Hospital 12 de Octubre
  4. 4 Universitat de Barcelona
    info

    Universitat de Barcelona

    Barcelona, España

    ROR https://ror.org/021018s57

  5. 5 Universitat Autònoma de Barcelona
    info

    Universitat Autònoma de Barcelona

    Barcelona, España

    ROR https://ror.org/052g8jq94

  6. 6 Unidad de Alcohol, Hospital Universitario Son Espases, Palma de Mallorca
  7. 7 Universidad de Valladolid
    info

    Universidad de Valladolid

    Valladolid, España

    ROR https://ror.org/01fvbaw18

  8. 8 Instituto de Investigación Biomédica-IBIMA, Málaga
Show affiliations +
Journal:
Adicciones: Revista de socidrogalcohol

ISSN: 0214-4840

Year of publication: 2018

Volume: 30

Issue: 4

Pages: 292-300

Type: Article

DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Adicciones: Revista de socidrogalcohol

Abstract

The Alcohol Program of the Spanish Network on Addictive Disorders-RTA requires a longitudinal study to address different research questions related to alcoholism. The cohort study (CohRTA) focuses on patients seeking treatment for alcohol use disorder, as a multicentre, collaborative research project aimed to improve secondary prevention and early diagnosis of pathological processes associated with the disorder. Methods: multicentre cohort study in adults (>18 years) seeking their first treatment of the disorder. Patients sign an informed consent and data is collected in an online platform specifically designed for the study; patients are also requested to provide biological samples that are stored in a biobank. Baseline and prospective, socio-demographic, epidemiological, clinical and treatment data are collected. Currently there are 10 participating centres that expect to recruit more than 1,000 patients. Results: As of December 2015, 344 patients (77% men) were included. Median age at admission was 50 years (IQR: 43-55 years). Median age at the start of alcohol consumption was 15 years (IQR: 14-18 years) and 61% of cases reported antecedents of alcohol use disorder in the family. During the 30 days prior to admission, alcohol consumption amounted to 12.5 SDU/day (IQR: 7.1-20 SDU/ day), 72% of the patients were tobacco smokers and 30% currently used cocaine. Organising an open cohort of patients with alcohol use disorder may be crucial to better understand the clinical consequences of alcoholism in Spain. This cohort may potentiate quantitative and qualitative research within the Spanish Network on Addictive Disorders-RTA/RETICS. Having a well-established, representative cohort of patients will increase translational research on consequences of alcoholism in our country.

Bibliographic References

  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Wasington, DC: American Psychiatric Association.
  • Bagnardi, V., Blangiardo, M., La Vecchia, C. y Corrao, G. (2001). Alcohol consumption and the risk of cancer: a meta-analysis. Alcohol Research & Health, 25, 263–270.
  • Bosque-Prous, M., Espelt, A., Guitart, A. M., Bartroli, M., Villalbí, J. R. y Brugal, M. T. (2014). Association between stricter alcohol advertising regulations and lower hazardous drinking across European countries. Addiction, 109, 1634–1643. doi: 10.1111/add.12562
  • Castillo, C., Bulbena, A., Serras, E., Torrens, M., López-Colomés, J. L., Martínez, M. A. y Politinska, B. (2004). Medical assessment in drug addicts: reliability and validity of the Cumulative Illness Rating Scale (Substance Abuse version). European Addiction Research, 10, 112–117. doi: 10.1159/000077699
  • Chamorro, A. J., Torres, J. L., Mirón-Canelo, J. A., González-Sarmiento, R., Laso, F. J. y Marcos, M. (2014). Systematic review with meta-analysis: the I148M variant of patatin-like phospholipase domain-containing 3 gene (PNPLA3) is significantly associated with alcoholic liver cirrhosis. Alimentary Pharmacology & Therapeutics, 40, 571–581.doi: 10.1111/apt.12890
  • Connor, J. P., Haber, P. S. y Hall, W. D. (2016). Alcohol use disorders. Lancet, 387, 988–998. doi: 10.1016/S01406736(15)00122-1
  • Fuster, D., Sanvisens, A., Bolao, F., Serra, I., Rivas, I., Tor, J. y Muga, R. (2015). Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patients. Journal of Viral Hepatitis, 22, 18–24.doi: 10.1111/jvh.12290
  • Gandek, B., Ware, J. E., Aaronson, N. K., Apolone, G., Bjorner, J. B., Brazier, J. E.,… Sullivan, M. (1998). Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology, 51, 1171–1178.
  • Gossop, M., Manning, V. y Ridge, G. (2006). Concurrent use and order of use of cocaine and alcohol: behavioural differences between users of crack cocaine and cocaine powder. Addiction, 101, 1292–1298.doi: 10.1111/j.13600443.2006.01497.x
  • Gual, A., Lligona, A. y Colom, J. (1999). Five-year outcome in alcohol dependence. A naturalistic study of 850 patients in Catalonia. Alcohol and Alcoholism, 34, 183–192.
  • Gual, A., Lligoña, A., Costa, S., Segura, L. y Colom, J. (2004).Tratamiento del alcoholismo y su impacto a largo plazo. Resultados a 10 años de un estudio longitudinal prospectivo de 850 pacientes. Medicina Clínica (Barcelona), 123, 364–369.
  • Gual, A. y Miquel, L. (2015). Nuevas perspectivas para el tratamiento del alcoholismo. Medicina Clínica (Barcelona), 144, 24–25. doi: 10.1016/j.medcli.2014.07.020
  • Heather, N. (2014). The two forms of alcohol brief intervention: an uneasy coalition. Addiction, 109, 1059–1060. doi: 10.1111/add.12443
  • López-Pelayo, H., Wallace, P., Segura, L., Miquel, L., Díaz, E., Teixidó, L.,… Gual, A. (2014). A randomised controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website (EFAR Spain): the study protocol. BMJ Open, 4, e007130.doi: 10.1136/bmjopen-2014-007130
  • McKee, P. A., Castelli, W. P., McNamara, P. M. y Kannel, W. B. (1971). The natural history of congestive heart failure: the Framingham study. The New England Journal of Medicine, 285, 1441–1446. doi: 10.1056/ NEJM197112232852601
  • Mdege, N. D., Fayter, D., Watson, J. M., Stirk, L., Sowden, A. y Godfrey C. (2013). Interventions for reducing alcohol consumption among general hospital inpatient heavy alcohol users: a systematic review. Drug and Alcohol Dependence, 131, 1–22. doi: 10.1016/j.drugalcdep.2013.01.023
  • Montesinos, J., Pascual, M., Pla, A., Maldonado, C., Rodríguez-Arias, M., Miñarro, J. y Guerri, C. (2015). TLR4 elimination prevents synaptic and myelin alterations and long-term cognitive dysfunctions in adolescent mice with intermittent ethanol treatment. Brain, Behavior and Immunity, 45, 233–244. doi: 10.1016/j.bbi.2014.11.015
  • Naimi, T. S., Brewer, R. D., Mokdad, A., Denny, C., Serdula, M. K. y Marks, J. S. (2003). Binge drinking among US adults. JAMA, 289, 70–75.
  • Nascetti, S., Elosua, R., Pena, A., Covas, M. I., Senti, M. y Marrugat, J. (2001). Variables associated with fibrinogen in a population-based study: interaction between smoking and age on fibrinogen concentration. European Journal of Epidemiology, 17, 953–958.
  • Nieto, J. A. y Monreal, M. (2004). Recurrent venous thromboembolism in men and women. The New England Journal of Medicine, 351, 2015–2018.
  • Nilsen, P., Baird, J., Mello, M. J., Nirenberg, T., Woolard, R., Bendtsen, P. y Longabaugh, R. (2008). A systematic review of emergency care brief alcohol interventions for injury patients. Journal of Substance Abuse Treatment, 35, 184–201.doi:10.1016/j.jsat.2007.09.008
  • Novo-Veleiro, I., González-Sarmiento, R., Cieza-Borrella, C., Pastor, I., Laso, F. J. y Marcos, M. (2014). A genetic variant in the microRNA-146a gene is associated with susceptibility to alcohol use disorders. European Psychiatry, 29, 288–292.doi: 10.1016/j.eurpsy.2014.02.002
  • Observatorio Español sobre Drogas, Delegación del Gobierno para el Plan Nacional sobre Drogas. (2011). Informe 2011. Situación y tendencias de los problemas de drogas en España. Madrid: Ministerio de Sanidad, Política Social e Igualdad.
  • Pascual, M., Baliño, P., Aragón, C. M. G. y Guerri, C. (2015). Cytokines and chemokines as biomarkers of ethanol-induced neuroinflammation and anxiety-related behavior: role of TLR4 and TLR2. Neuropharmacology, 89, 352–359. doi: 10.1016/j.neuropharm.2014.10.014
  • Pennings, E. J. M., Leccese, A. P. y de Wolff, F. A. (2002). Effects of concurrent use of alcohol and cocaine. Addiction, 97, 773–783.
  • Pons, J. M. V., Rodés, J., Andreu, A. y Arenas, J. (2013). La olvidada investigación clínica. Medicina Clínica (Barcelona), 140, 325–331.doi: 10.1016/j.medcli.2012.10.011
  • Pulido, J., Brugal, M. T., de la Fuente, L., Ballesta, R., Barrio, G., Bravo, M. J.,… Fernández, F. (2009). Metodología de reclutamiento y características de una cohorte de jóvenes consumidores habituales de cocaína de tres ciudades españolas. Gaceta Sanitaria, 23, 200–207.doi: 10.1016/j.gaceta.2008.05.003
  • Rivas, I., Sanvisens, A., Bolao, F., Fuster, D., Tor, J., Pujol, R.,… Muga, R. (2013). Impact of medical comorbidity and risk of death in 680 patients with alcohol use disorders. Alcoholism, Clinical and Experimental Research, 37 Suppl 1, E221–E227.doi: 10.1111/j.15300277.2012.01861.x
  • Roerecke, M. y Rehm, J. (2013). Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction, 108, 1562–1578.doi: 10.1111/add.12231
  • Salyers, M. P., Bosworth, H. B., Swanson, J. W., Lamb-Pagone, J. y Osher, F. C. (2000). Reliability and validity of the SF-12 health survey among people with severe mental illness. Medical Care, 38, 1141–1150.
  • Sanvisens, A., Vallecillo, G., Bolao, F., Rivas, I., Fonseca, F., Fuster, D.,… Muga, R. (2014). Temporal trends in the survival of drug and alcohol abusers according to the primary drug of admission to treatment in Spain. Drug and Alcohol Dependence, 136, 115-120. doi: 10.1016/j.drugalcdep.2013.12.022
  • Sobrino-Vegas, P., Gutiérrez, F., Berenguer, J., Labarga, P., García, F., Alejos-Ferreras, B.,… del Amo, J. (2011). La cohorte de la red española de investigación en Sida y su biobanco: organización, principales resultados y pérdidas de seguimiento . Enfermedades Infecciosas y Microbiología Clínica, 29, 645–653.doi: 10.1016/j.eimc.2011.06.002
  • Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N.,… Vlahov, D. (2000). The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA, 284, 450–456.
  • Villalbí, J. R., Bosque-Prous, M., Gili-Miner, M., Espelt, A. y Brugal, M. T. (2014). Políticas para prevenir los daños causados por el alcohol. Revista Española de Salud Pública, 88, 515–528.doi: 10.4321/S1135-57272014000400006
  • World Health Organization. (2010). Global Status Report on Alcohol. Ginebra: World Health Organization.
Data source: Dialnet